Convener: Helen Davis, North West Medicines Information Centre
The SPS Medicines Access Group (formerly the UKMi Horizon Scanning and Medicines Evaluation Working Group) aims to identify and respond to NHS needs to help maintain patients’ access to medicines and appropriate treatment.
It is responsible for developing a strategy for co-ordinated production of information to support managed introduction of new medicines into the NHS. The information encompasses early horizon scanning intelligence through to evaluations of medicines once marketed. They liaise with other organisations on new product work.
The Group is also responsible for co-ordinating information on product shortages.